A randomized phase <scp>II</scp> study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring <scp> <i>EGFR</i> </scp> mutations ( <scp>JMTO LC12</scp> ‐01)-Reference-Cited by-同舟云学术

A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations ( JMTO LC12 ‐01)

Published:2022-05-13 Issue:12 Volume:13 Page:1827-1836
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Asami Kazuhiro¹^ORCID,Ando Masahiko²,Nishimura Takashi³,Yokoi Takashi⁴,Tamura Atsuhisa⁵,Minato Koichi⁶,Mori Masahide⁷,Ogushi Fumitaka⁸^ORCID,Yamamoto Akiyoshi⁹,Yoshioka Hiroshige¹⁰,Kawahara Masaaki¹¹,Atagi Shinji¹²

Affiliation:

1. Asami Naika Clinic Tokyo Japan

2. Department of Advanced Medicine Nagoya University Hospital Nagoya Japan

3. Department of Respiratory Medicine Kyoto Katsura Hospital Kyoto Japan

4. Department of Thoracic Oncology Hyogo College of Medicine Hyogo Japan

5. Department of Center for Pulmonary Diseases Tokyo National Hospital Tokyo Japan

6. Department of Respiratory Medicine Gunma Prefectural Cancer Center Gunma Japan

7. Department of Thoracic Oncology National Hospital Organization Osaka Toneyama Medical Center Osaka Japan

8. Department of Respiratory Medicine Kochi National Hospital Kochi Japan

9. Department of Respiratory Medicine Takamatsu Red Cross Hospital Kagawa Japan

10. Department of Thoracic Oncology Kansai Medical University Hospital Osaka Japan

11. Department of Respiratory Medicine KKR Otemae Hospital Osaka Japan

12. Department of Thoracic Oncology National Hospital Organization Kinki‐Chuo Chest Medical Center Osaka Japan

Funder

AstraZeneca Pharma Poland

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14465

Reference45 articles.

1. Global Epidemiology of Lung Cancer

2. Death rates fall for 8 of 10 top causes; Alzheimer's up to no. 6;Hosp Health Netw,2008

3. Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift

4. Predicting the Epidemiological Dynamics of Lung Cancer in Japan

5. Advanced Non-Small-Cell Lung Cancer in Elderly Patients: Patient Features and Therapeutic Management

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-task learning for predicting synergistic drug combinations based on auto-encoding multi-relational graphs;iScience;2023-10